Cambrian's revenue surged by 4347.82% year-on-year in the first half of the year, and the AI ​​chip track explodedRecently, Cambrian (688256.SH) released its first half of 2023 financial report. Data showed that its revenue surged by 4347.82% year-on-year, becoming the most dazzling "dark horse"

Encourage traditional Chinese medicine service export bases and international medical insurance institutions to strengthen cooperationIn recent years, the influence of traditional Chinese medicine on a global scale has been increasing, and more and more countries and regions have begun to recognize

Darui Bio's new GalNAc-siRNA drug RN3161 targeted to INHBE was accepted in Australia's clinical trial application, aiming to lose fat while maintaining weight lossRecently, Darui Bio announced that its new GalNAc-siRNA drug RN3161 developed by it has been accepted in Australia's clinical trial appli

REGENXBIO gene therapy RGX-121 is used to treat type II mucopolysaccharide storage disorder (MPS II) published positive clinical dataRecently, biotechnology company REGENXBIO released positive clinical data on its gene therapy RGX-121 for the treatment of type II mucopolysaccharide storage disorder

The 2025 China Rare Disease Summit Forum will be held in Wuhan from September 19 to 21Recently, the preparations for the 2025 China Rare Disease Summit Forum were officially launched. This highly anticipated industry event is scheduled to be held at the Wuhan International Expo Center from September